Humanwell Healthcare (Group) Co (SHSE:600079) Enterprise Value: ¥35,392 Mil (As of Jul. 13, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600079 Humanwell Healthcare (Group) Co Ltd SHSE:600079
61 GF Score
Price ¥17.55
GF Value ¥21.63
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Humanwell Healthcare (Group) Co Enterprise Value?

Humanwell Healthcare (Group) Co SHSE:600079 +0.98% 61 Enterprise Value is ¥35,392 Mil as of Jul. 13, 2026. GuruFocus rates SHSE:600079 with a GF Score™ of 61/100 and a GF Value™ of ¥21.63 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Humanwell Healthcare (Group) Co's Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3,412 Mil. Therefore, Humanwell Healthcare (Group) Co's EV-to-EBIT ratio for today is 10.37.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Humanwell Healthcare (Group) Co's Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3,412 Mil. Therefore, Humanwell Healthcare (Group) Co's EV-to-EBITDA ratio for today is 10.37.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Humanwell Healthcare (Group) Co's Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ¥23,926 Mil. Therefore, Humanwell Healthcare (Group) Co's EV-to-Revenue ratio for today is 1.48.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Humanwell Healthcare (Group) Co's Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3,136 Mil. Therefore, Humanwell Healthcare (Group) Co's EV-to-OCF ratio for today is 11.28.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Humanwell Healthcare (Group) Co's Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥2,560 Mil. Therefore, Humanwell Healthcare (Group) Co's EV-to-FCF ratio for today is 13.82.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Humanwell Healthcare (Group) Co  (SHSE:600079) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Humanwell Healthcare (Group) Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=35391.932/3412.257
=10.37

Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil.
Humanwell Healthcare (Group) Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,412 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Humanwell Healthcare (Group) Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=35391.932/3412.257
=10.37

Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil.
Humanwell Healthcare (Group) Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,412 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Humanwell Healthcare (Group) Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=35391.932/23925.859
=1.48

Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil.
Humanwell Healthcare (Group) Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥23,926 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Humanwell Healthcare (Group) Co's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=35391.932/3136.429
=11.28

Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil.
Humanwell Healthcare (Group) Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,136 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Humanwell Healthcare (Group) Co's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=35391.932/2560.419
=13.82

Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil.
Humanwell Healthcare (Group) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,560 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humanwell Healthcare (Group) Co Enterprise Value Related Terms


Humanwell Healthcare (Group) Co Enterprise Value Historical Data

* Premium members only.

The historical data trend for Humanwell Healthcare (Group) Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co Enterprise Value Chart

Humanwell Healthcare (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46,346.28 46,036.57 47,916.00 45,555.44 36,264.39

Humanwell Healthcare (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41,837.72 41,603.81 41,603.54 36,264.39 37,481.18

SHSE:600079 vs ZTS, UTHR: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humanwell Healthcare (Group) Co Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Humanwell Healthcare (Group) Co's Enterprise Value falls into.


SHSE:600079
61GF Score
Humanwell Healthcare (Group) Co Ltd SHSE:600079
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humanwell Healthcare (Group) Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Humanwell Healthcare (Group) Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Humanwell Healthcare (Group) Co's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ¥35,392 Mil mean?
Humanwell Healthcare (Group) Co (SHSE:600079) has a Enterprise Value of ¥35,392 Mil as of Jul. 13, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Humanwell Healthcare (Group) Co and its competitors.
Is Humanwell Healthcare (Group) Co's Enterprise Value too high?
Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Enterprise Value compare to ZTS and UTHR?
Humanwell Healthcare (Group) Co's Enterprise Value of ¥35,392 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Humanwell Healthcare (Group) Co and its competitors. Humanwell Healthcare (Group) Co's current Enterprise Value is ¥35,392 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.63, compared to a current price of ¥17.55 — trading 18.9% below its estimated fair value. The current Enterprise Value is ¥35,392 Mil. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Enterprise Value is ¥35,392 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?

Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued. The current stock price of ¥17.55 is trading 18.9% below its estimated GF Value™ of ¥21.63. GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:600079:

  • Enterprise Value: ¥35,392 Mil
  • GF Value™: ¥21.63 vs. price of ¥17.55 (18.9% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humanwell Healthcare (Group) Co Business Description

Address No. 666, Gaoxin Avenue, East Lake High-tech Development Zone, Hubei Province, Wuhan, CHN, 430075
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score

Get the complete analysis for SHSE:600079

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.55
Price
¥21.63
GF Value